[Federal Register Volume 78, Number 219 (Wednesday, November 13, 2013)]
[Notices]
[Pages 68074-68075]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-27083]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30 Day-13-13ZZ]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
(404) 639-7570 or send an email to [email protected]. Send written comments 
to CDC Desk Officer, Office of Management and Budget, Washington, DC 
20503 or by fax to (202) 395-5806.

[[Page 68075]]

Written comments should be received within 30 days of this notice.

Proposed Project

    Evaluation of the SAMHSA PDMP Electronic Health Record (EHR) 
Integration and Interoperability Expansion Program--New--National 
Center for Injury Prevention and Control (NCIPC), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    In 2009, drug overdose deaths became the leading cause of injury 
death in the United States (U.S.), exceeding motor vehicle traffic 
crash deaths for the first time, a trend that continued in 2010. 
Prescription drugs, particularly opioid pain relievers, have been 
identified as the main driver of this increase. The number of overdose 
deaths per year involving opioid pain relievers increased more than 
four-fold from 1999 to 2010 (from 4,030 to 16,651), outnumbering 
overdose deaths involving all illicit drugs combined. Morbidity 
associated with opioid pain reliever abuse increased in parallel. The 
rate of emergency department visits associated with the misuse or abuse 
use of opioid pain relievers increased 153% from 2004 to 2011, while 
rates for illicit drugs remained largely stable.
    This project involves an evaluation of the Substance Abuse and 
Mental Health Services (SAMHSA) Prescription Drug Monitoring Program 
(PDMP) Electronic Health Record (EHR) Integration and Interoperability 
Expansion Program (PEHRIIE) which has funded projects in nine states 
via cooperative agreements.
    Under these cooperative agreements, the Centers for Disease Control 
and Prevention (CDC) is responsible for conducting a comprehensive 
process and outcomes evaluation of the PEHRIIE program. The primary 
goals of the qualitative evaluation component of this work are:
    1. To understand the processes, challenges, and successes in 
implementing and sustaining integration of PDMP data with Health 
Information Technology (HIT) systems and interoperability of PDMP 
systems across states; and
    2. To understand the experiences of clinical end users with the 
systems being upgraded under the PEHRIIE program and to capture their 
recommendations, if any, for how the goals of the PEHRIIE could have 
been better accomplished.
    In order to achieve these evaluation goals, CDC requests OMB 
approval for 24 months in order for the CDC evaluation team to conduct 
qualitative interviews with those individuals involved in the planning 
and implementation of the PEHRIIE projects (i.e., key project staff and 
stakeholders) as well as with the clinical end users (i.e., prescribers 
and pharmacists) of the PDMPs in the states where these projects are 
taking place. Through this evaluation, CDC will better understand the 
impact of PDMP integration and interoperability in the funded states.
    The total annual estimated burden hours for the planned qualitative 
information collection are 119 hours. Total burden time includes the 
time to conduct interviews with key project staff/stakeholders and 
clinical end users, and the time spent by recruiters at the PEHRIIE 
implementation sites to identify potential clinical end user 
interviewees.
    Staff/stakeholder interviews will be conducted with key project 
staff members/stakeholders across the nine PEHRIIE-funded states. 
Interviews will also be conducted with key project staff/stakeholders 
representing companies working with multiples states involved in the 
PEHRIIE program.
    End user interviews will be conducted at implementation sites 
distributed across all nine PEHRIIE states. The CDC will work with one 
recruiter per implementation site to complete these tasks.
    There are no costs to respondents other than their time. The total 
estimated annual burden hours are 119 hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden  per
          Type of respondent                    Form name           respondents    responses per   response  (in
                                                                                    respondent         hrs)
----------------------------------------------------------------------------------------------------------------
Key Project Staff/Stakeholders          Key Project Staff/                    53               1           45/60
                                         Stakeholders Interview
                                         Guide
Clinical End Users                      End Users Interview                   59               1               1
                                         Guide
Clinical End User Recruiters            N/A.....................              20               1               1
----------------------------------------------------------------------------------------------------------------


Kimberly S. Lane,
Deputy Director, Office of Science Integrity, Office of the Associate 
Director for Science, Office of the Director, Centers for Disease 
Control and Prevention.
[FR Doc. 2013-27083 Filed 11-12-13; 8:45 am]
BILLING CODE 4163-18-P